SINO BIOPHARMACEUTIC | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (38)

View All

Latest Posts

About This Stock More About This Stock
Week In Review: HighlightLL Pharma Out-Licenses Parkinson's Treatment To Biohaven For $970 Million
Article By: ChinaBio® Today
Saturday, March 25, 2023 2:19 PM EDT
HighlightLL Pharma out-licensed rights to its novel oral, brain-penetrating, dual inhibitor to New Haven’s Biohaven in a deal worth up to $970 million. Biohaven will have global rights to the product for $10 million upfront and $10 million in equity.
In this article: BHVN Also: SBMFF, TAK, CNTB
Read
Week In Review: China Life Science Posts $1.3 Billion In Deals
Article By: ChinaBio® Today
Saturday, August 7, 2021 1:47 PM EDT
Pacific Biosciences, a San Francisco Bay area company offering long-read sequencing platforms, will acquire Omniome for up to $800 million. Zai Lab and Schrödinger formed a collaboration to develop a novel oncology product targeting DNA damage.
In this article: SBMFF, PACB, SDGR, BYSI, ZLAB, ZNTL, 2696.HK, 9926.HK
Read
Week In Review: Three China In-Licensing Deals Add Up To $662 Million
Article By: ChinaBio® Today
Saturday, April 3, 2021 2:56 PM EDT
Simcere Pharma of Nanjing announced a $292 million agreement to develop a proposed Kazia Therapeutics treatment for glioma in Greater China. Qihan Biotechnology raised $67 million in a Series A++ round to advance its portfolio of cell therapies.
In this article: SCR, SBMFF, SVA, GILD, BYSI, ZLAB, DCPH, KZIA
Read
Week In Review: China Life Science Books $1 Billion In Ten Announced Deals
Article By: ChinaBio® Today
Saturday, March 27, 2021 12:57 PM EDT
Sino Biopharm announced a deal worth up to $200 million to acquire a 60% stake in Softhale, a Belgium company. Brii Biosciences, a Shanghai-US company developing anti-infectives and CNS products for China, completed a $155 million Series C financing.
In this article: BMY, GNE, CASI, CIHHF, SBMFF
Read
Week In Review: $1.2 Billion In China Life Science Deals, IPOs, And Financings
Article By: ChinaBio® Today
Saturday, March 20, 2021 1:31 PM EDT
Just two months into 2021 and it already looks as though the momentum from 2020's record-setting levels of China life science activity continues into the new year. Most 2020 metrics for China life science doubled their 2019 results.
In this article: PFE, SBMFF, BGNE, SCYX
Read
All Posts

Latest Tweets for $SBMFF

No tweets yet!

PARTNER HEADLINES